Navigation Links
Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology

Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com .

This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, Boston Scientific's overall business strategy, and other factors described in Boston Scientific's filings with the Securities and Exchange Commission.

    CONTACT:  Paul Donovan

              508-650-8541 (office)

              508-667-5165 (mobile)

              Media Relations

              Boston Scientific Corporation


              Dan Brennan

              508-650-8538 (office)

              617-459-2703 (mobile)

              Investor Relations

              Boston Scientific Corporation

(1) The TAXUS Liberte stent is currently pending approval by the U.S. Food and Drug Administration and is not available for sale in the United States.

(2) Defined as B2 or C lesions (ACC/AHA lesion type)

Boston Scientific Corporation

CONTACT: Paul Donovan, Media Relations, +1-508-650-8541, Mobile,+1-508-667-5165, or Dan Brennan, Investor Relations, +1-508-650-8538,Mobile, +1-617-459-2703, both of Boston Scientific Corporation

Web site: http://www.bostonscientific.com/

Ticker Symbol: (NYSE:BSX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Busi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

Post Your Comments:
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstCa...mpanymanufacturingpoint-of-carebloodanalysissystem...executiveofficer,willpresentatthe21stAnnualPiperJa...9at2:00p.m.ET.TheconferencewillbeheldattheNewYorkP... Abaxisdevelops,manufacturesandmarketsportablebloo...
(Date:11/25/2009)...,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cempra...rnandes,presidentandchiefexecutiveofficer,willpres...at8:50a.m.EST,December1,2009,atTheNewYorkPalaceHot...fthecompany,stwoleadingantibioticclinicalprogramsf...SA. ,, AboutCempraPharmaceuticals ,, Found...
(Date:11/25/2009)...,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswir...HTWR ;ASX:HIN),aleadinginnovatorandprovideroflessi...revolutionizingthetreatmentofadvancedheartfailure,...sentationatthe21stAnnualPiperJaffrayHealthCareConf...ferenceisbeingheldattheNewYorkPalaceHotel,December...
Breaking Medicine Technology:WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference 6355 1Need for emergency airway surgery for hard to intubate patients reduced 61570 1Need for emergency airway surgery for hard to intubate patients reduced 61570 2Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 1Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 2Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 3
... EVEN MORE SCIENCE SUPPORTING THE, THEORY THAT VA... A primate model for autism,using the U.S. childr...ernational Meeting For Autism Research (IMFAR) thi...eed for studies into vaccine safety and,the immune...n. The National,Autism Association (NAA) questions...
...rapeutics present preliminary Phase II data ...ated and mechanically-ventilate...lthCare,together with Nektar Therapeutics (Nasdaq:...se II data on their unique drug-device combination...(ATS) annual meeting. Amikacin,Inhale, currently b...
Other Medicine Technology:UPDATE: Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Behavioral Symptoms of Autism 2Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7
(Date:11/25/2009)...EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- ...cedthatthecompanywillhosttwoinvestoreventsinDecemb...:00a.m.CT/10:00a.m.ET ,, Principalinvestigato...ibinrelapsedand/orrefractorymultiplemyeloma,asfeat...lMeetingandExpositioninNewOrleans,LA.Theteleconfer...
(Date:11/25/2009)...LOSANGELES,Nov.25/PRNewswire-USNewswire/--TheBlack...odetermineexecutiveleadershipfor2010. ,, Thenew...cialtiesinpublicpolicy,law,finance,governmenthealt...eBoardalsocomesfromawiderangeofpersonalbackgrounds...melivingwithHIVthemselves,andrepresentingmultiplea...
(Date:11/25/2009)...rtuitous discovery that grew out of a collaboratio...ntially offer hope to the nearly 10 million Americ... , Also known as hardening of the arteries, pe...culatory problem in which narrowed arteries reduce...red a red flag for vascular disease, heart attack ...
(Date:11/25/2009)... forgetfulness could lead mothers to overlook need... 25 (HealthDay News) -- A mother,s depression can ...ound. , Their six-month study of 262 black moth...others had more depressive symptoms had more frequ...h fewer depressive symptoms had less frequent asth...
(Date:11/25/2009)... LittleImprovementShownforthe4thStraightYear ,...day,LungCancerAlliance-Georgia(LCA-GA)issuedthe 4t...smentofprogressbeingmadeagainstthislethaldiseasein...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Logo: http://www....
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...experts reported that women in India are gradually...d they comprise about 40 percent of India’s infect...e susceptible to HIV infection. Besides, gender di...n security unit, United Nations Development Fund f...
...entists have now found that women who skip their m...r methods are less likely to develop cancers// rel...vical cancer, uterine cancer, ovarian cancer. ...varian and endometrial cancers, says Professor Ian...
...ach may have some beneficial effects in fighting c...cancer have the potential to perform better with t...body’s immune system to recognize cancer tissues a...ity College London (UCL) have been able to place a...
... Cancer patients who actively use the internet to ... positive outlook, and are well aware of the possi...ried out by the Temple University and has been pub...eiterated that this is the first study that has so...
... referral management centres have been blamed for ...for surgery. These centres that dictate the where ...between the hospitals and GPs. Officials belonging...s are currently being managed by staff belonging t...
...st plastic surgeons to be greedier! Not satisfied ...splant on a French woman, plastic surgeons are hun...Reporting in the March issue of Plastic and Recons...dure of a full-face transplant. "For the fir...
Other Medicine News:Health News:Biologically Women Are More Vulnerable To HIV Infection 2Health News:Internet Research Fosters Confidence and Positivity in Cancer Patients 2Health News:Referral Schemes Blamed By GPs For Treatment Delay 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: